Clinical trial design issues in schizophrenic research

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 9, 2001, Pages 17-22

  Casey, Daniel E ^a  

^a PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; FLUPHENAZINE DECANOATE; HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT; OLANZAPINE; PLACEBO; QUETIAPINE; RISPERIDONE;

CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; DRUG USE; FOOD AND DRUG ADMINISTRATION; HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS; DRUG APPROVAL; HUMANS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SCHIZOPHRENIA; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0035018112     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Tran PV, Hamilton SH, Kuntz AJ, et al. Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol 1997;17:407-418
2. Conley RR, Love RC, Kelly DL, et al. A comparison of rehospitalization rates between patients treated with atypical antipsychotics and those treated with depot antipsychotics. Presented at the 54th Annual Convention and Scientific Program of the Society of Biological Psychiatry; May 13-15, 1999; Washington, DC
3. Ho B-C, Miller D, Nopoulos P, et al. A comparative effectiveness study of risperidone and olanzapine in the treatment of schizophrenia. J Clin Psychiatry 1999;60:658-663
4. Conley RR, Mahmoud R, and the Risperidone Study Group. Risperidone versus olanzapine in patients with schizophrenia and schizoaffective disorder. Presented at the 38th annual meeting of the American College of Neuropsychopharmacology; Dec 12-16, 1999; Acapulco, Mexico
5. Mullen J, Reinstein M, Bari M, et al. Quetiapine and risperidone in outpatients with psychotic disorders: results of the QUEST trial. Presented at the biennial meeting of the International Congress on Schizophrenia Research; April 17-21, 1999; Santa Fe, NM
6. Angst J, Bech P, Bobon D, et al. Report on the Third Consensus Conference on the Methodology of Clinical Trials With Antipsychotic Drugs. Pharmacopsychiatry 1991;24:149-152
7. Hotopf M, Churchill R, Lewis G. Pragmatic randomized controlled trials in psychiatry. Br J Psychiatry 1999;175:217-223
8. Collaborative Working Group on Clinical Trial Evaluations. Clinical development of atypical antipsychotics: research design and evaluation. J Clin Psychiatry 1998;59(suppl 12):10-16
9. Journal of the American Medical Association resources page. Glossary of methodologic terms. Available at: http://jama.ama-assn.org/info/auinst_ term.html. Accessed April 17, 2000
10. Summerfelt WT, Meltzer HY. Efficacy vs effectiveness in psychiatric research [letter with reply]. Psychiatr Ser 1998;49:834